Few studies showed that the activity of PKC is decreased in the brains of Alzheimer’s Disease patients (Wang et al., 1994; Matsushima et al., 1996), suggesting potential adverse effects of its diminished activity. The gene discussed is PRRT2; the disease is Alzheimer disease.